Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Author:

Corman Victor M1,Landt Olfert2,Kaiser Marco3,Molenkamp Richard4,Meijer Adam5,Chu Daniel KW6,Bleicker Tobias1,Brünink Sebastian1,Schneider Julia1,Schmidt Marie Luisa1,Mulders Daphne GJC4,Haagmans Bart L4,van der Veer Bas5,van den Brink Sharon5,Wijsman Lisa5,Goderski Gabriel5,Romette Jean-Louis7,Ellis Joanna8,Zambon Maria8,Peiris Malik6,Goossens Herman9,Reusken Chantal5,Koopmans Marion PG4,Drosten Christian1

Affiliation:

1. Charité – Universitätsmedizin Berlin Institute of Virology, Berlin, Germany and German Centre for Infection Research (DZIF), Berlin, Germany

2. Tib-Molbiol, Berlin, Germany

3. GenExpress GmbH, Berlin, Germany*

4. Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands

5. National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands

6. University of Hong Kong, Hong Kong, China

7. Universite d Aix-Marseille, Marseille, France

8. Public Health England, London, United Kingdom

9. Department of Medical Microbiology, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium

Abstract

Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. Aim We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. Methods Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. Results The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive – Global (EVAg), a European Union infrastructure project. Conclusion The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference22 articles.

1. The severe acute respiratory syndrome.;Peiris;N Engl J Med,2003

Cited by 6869 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3